Penicillin and Streptomycin Market Set To Rise Investments On R & D Of Penicillin & Streptomycin

Penicillin and Streptomycin

The Penicillin and Streptomycin Market deals with the development of antibiotics namely penicillin and streptomycin to prevent diseases caused due to bacteria. Penicillin and streptomycin are two of the most widely prescribed antibiotics, which are capable of preventing bacteria growth.

Basically, penicillin is derived from Penicillium and streptomycin is derived from actinobacterium Streptomyces griseus. Streptomycin is widely used in the treatment of Tuberculosis, along with other drugs. These are manufactured by three types of processes, natural, synthetic and semi-synthetic. These two antibiotics are generally used in pharmaceuticals, hospitals and clinics. Increasing number of infectious diseases is the major growth driver of the Penicillin and Streptomycin Market.

Scope & Regional Forecast of the Penicillin and Streptomycin Market

Rising investments on research and development of penicillin streptomycin antibiotics and stringent government regulations are some of the key growth factors of the Penicillin and Streptomycin Market. Increasing demand for generics and high incidences of anti-microbial resistance are the major factors which will drive the growth and development of new products in this market. The market has growth opportunities with innovations in new product development and usage of penicillin-streptomycin compound in cell culture as anti-bacterial agent.

Penicillin and Streptomycin Market Boosted By Increasing Demand For Generics

Government regulations and patent expiry issues are major challenges to the growth of the Penicillin and Streptomycin Market. In addition, increasing incidences of anti-microbial resistance coupled with adoption of different types of antibiotics which have less side effects when compared with penicillin and streptomycin are also impeding the growth of the market.

North America is holding the highest market share followed by Europe. Asia-Pacific is estimated to witness the highest growth for the Penicillin and Streptomycin Market, due to large population base improving healthcare infrastructure, rising health awareness and high disposable income in emerging economies like India, China and Australia.

Segmentations & Key Players Involved in the Penicillin and Streptomycin Market

According to IndustryARC findings, the Penicillin and Streptomycin Market can be broken down into various segmentations on the basis of –

  • Product Type: Penicillin and Streptomycin.

  • Route of Administration: Oral, Intramuscular and Intravenous.

  • Manufacturing process: Natural, Synthetic and Semi-Synthetic.

  • End User: Pharmaceuticals, Hospitals and Clinics/ASC’s.

  • Region: Americas, Europe, Asia-Pacific and Rest of the World.

Some of the key players involved in the Penicillin and Streptomycin Market according to IndustryARC are as follows:

  • Abbot Laboratories

  • Johnson & Johnson

  • Celgine Corporation

  • Roche Pharmaceuticals

  • Takeda Pharmaceutical Company

Request For Table Of Contents @ http://www.industryarc.com/pdfdownload.php?id=15050